Dual acting oral floating matrix tablets of ranitidine hydrochloride.
Loading...
Date
2010-08
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The main purpose of this work was to prepare floating matrix drug delivery system of Ranitidine.
Floating matrix tablets of Ranitidine were developed to prolong gastric residence time and increase its
bioavailability. Rapid gastrointestinal transit could result in incomplete drug release from the drug delivery
system above the absorption zone leading to diminished efficacy of the administered dose. Floating matrix
tablets containing 100 mg Ranitidine were developed using different effervescent salts and polymer
combinations. The tablets were prepared by direct compression technique, using polymers such as hydroxyl
propyl methyl cellulose (HPMC K4M), Carbopol 934 in combination. Sodium bicarbonate, citric acid, calcium
carbonate was incorporated as a gas-generating agent. The effects of sodium bicarbonate on drug release profile
and floating properties were investigated. The formulation was optimized on the basis of acceptable tablet
properties, floating lag time, total duration of floating and in vitro drug release. The formulated tablets with
optimum hardness, uniform thickness, consistent weight uniformity and low friability. The results of dissolution
studies, floating lag time indicated that formulations F4 exhibited good and controlled drug release. Applying
the linear regression analysis and model fitting showed the selected formulation F4 showed diffusion coupled
with erosion drug release mechanism, followed first order kinetics. Optimized floating matrix tablets F4 showed
no change in physical appearance, drug content, or in dissolution pattern after storage at 250C/ relative humidity
65% and 40°C / relative humidity 75% for a period of 3 months.
Description
Keywords
Ranitidine, floating tablets, direct granulation, in vitro release
Citation
Kumar D Jagadeesh, Ahad Hindustan Abdul, Anuradha C M, Kumar Chitta Suresh, Reddy B Kishore Kumar, Savithri R. Dual acting oral floating matrix tablets of ranitidine hydrochloride. International Journal of Applied Biology and Pharmaceutical Technology. 2010 Aug-Oct; 1(2): 602-607.